Valiant Organics Declares Q3 Financial Results
Valiant Organics, a smallcap pharmaceutical company, recently declared its financial results for the quarter ended September 2023. The company's net sales for the quarter showed a slight growth of 0.62% compared to the previous quarter, but a significant decline of -25.63% compared to the same quarter last year. The consolidated net profit also saw a decline of -65.38% compared to the previous quarter.
The company's operating profit (PBDIT) excluding other income also saw a decline of -35.08% compared to the previous quarter. However, the interest expenses for the quarter saw a decrease of -11.37% compared to the previous quarter. The operating profit margin (excluding other income) also saw a decline from the previous quarter.
Despite the negative financial performance for the quarter, Valiant Organics has shown some positive aspects in its financials. The company has generated the highest operating cash flow in the last three years and has also reduced its debt-equity ratio in the last five half-yearly periods.
However, there are some areas of concern for the company. The net sales for the quarter have shown a significant decline of -23.09% compared to the same quarter last year, indicating a negative sales trend in the near term. The profit before tax (PBT) has also seen a decline of -91.37% compared to the same quarter last year, and the profit after tax (PAT) has also seen a decline of -79.5%.
The company's interest expenses have increased, indicating a rise in borrowings, and its ability to manage interest payments has deteriorated. The operating profit margin and PBT have also seen a decline in the last five quarters. The company's earnings per share (EPS) have also decreased, creating lower earnings for shareholders.
In addition, the company's short-term liquidity has deteriorated, and its income from non-business activities is high, which may not be a sustainable business model. Valiant Organics has a lot to work on to improve its financial performance in the coming quarters.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
{{text.big_txt}}
{{text .small_txt}}
{{dashverdictresult.dashboard.stock_details.short_name}}
SEND BY EMAIL
Register now to see if the stock’s characteristics match your investment style
Subscribe now to see if the stock's characteristics match your investment style
{{dashverdictresult.dashboard.risk_return_voltality.risk_type}}, {{dashverdictresult.dashboard.risk_return_voltality.return_type}}
| {{ value[0] }} | {{ value[1] }} | {{ value[2] }} | {{ value[3] }} |
| {{ value[0] }} | {{ value[1] }} | {{ value[2] }} | {{ value[3] }} |
Create your portfolio and know how much should this stock be in your portfolio
Subscribe now to know how much you should hold in this stock
We have found 2 better stocks that you can consider
{{dashverdictresult.dashboard.return_text}}
Investors Returns (3 years) –
| Period | 6M | 1Y | 2Y | 3Y |
| {{ keyd.val }} | ||||
| {{ keyd.val }} |
Quality: {{dashverdictresult.dashboard.dotsummary.q_txt}}
Valuation: {{dashverdictresult.dashboard.dotsummary.v_txt}}
Quarterly Financial Trend: {{dashverdictresult.dashboard.dotsummary.f_txt}}
Technicals: {{dashverdictresult.dashboard.dotsummary.tech_txt}}
Stock Info:
BSE – {{dashverdictresult.dashboard.stock_details.scripcode}}/ NSE – {{dashverdictresult.dashboard.stock_details.symbol}}
Market Cap – {{dashverdictresult.dashboard.priceinfo.mcap_class}} (Rs. {{dashverdictresult.dashboard.priceinfo.mcap| number :0}} cr)
Sector – {{dashverdictresult.dashboard.stock_details.ind_name}}
52 w H/L (Rs.) – {{dashverdictresult.dashboard.priceinfo.wk_high52}}/{{dashverdictresult.dashboard.priceinfo.wk_low52}}
Average vol (6M) – {{dashverdictresult.dashboard.priceinfo.vol}}
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
